Expression of neural cell adhesion molecule L1 in human lung cancer cell lines

Cell Structure and Function

Volumn 22, Issue 5, 1997, Pages 511-516

  Katayama, Masahiro ^a   Iwamatsu, Akihiko ^b   Masutani, Hiroshi ^a   Furuke, Keizo ^a   Takeda, Kazumasa ^a   Wada, Hiromi ^a   Masuda, Tohru ^a   Ishii, Kazuhiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

Carcinoma; Cell adhesion molecule L1; Lung cancer; Monoclonal antibody; Neuroblastoma

Indexed keywords

NERVE CELL ADHESION MOLECULE;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; MYELOMA CELL; NEUROBLASTOMA CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPLEEN CELL;

ANIMALIA;

EID: 0031457089     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.22.511     Document Type: Article

References (33)

1. ALLAN, P.M., GARSON, J.A., HARPER, E.I., ASSER, U., COAKHAM, H.B., BROWNELL, B., and KEMSHEAD, J.T. 1983. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int. J. Cancer, 31: 591-598.
2. AMSTUTZ, H., RYTZ, Ch., NOVAK-HOFER, I., SPYCHER, M., SCHUBIGER, P.A., BLASER, K., and MORGENTHALER, J.-J. 1993. Production and characterization of a mouse/human chimeric antibody directed against human neuroblastoma. Int. J. Cancer, 53: 147-152.
3. COAKHAM, H.B., GARSON, J.A., ALLAN, P.M., HARPER, E.I., BROWNELL, B., KEMSHEAD, J.T., and LANE, E.B. 1985. Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel. J. Clin. Pathol., 38: 165-173.
4. CUATRECASAS, P., WILCHECK, M., and ANFINSEN, C.B. 1968. Selective enzyme purification by affinity chromatography. Proc. Natl. Acad. Sci. USA, 61: 636-643.
5. EDELMAN, G.M. and CROSSIN, K.L. 1991. Cell adhesion molecules: Implications for a molecular histology. Annu. Rev. Biochem., 60: 155-190.
6. FRANKE, W.W., SCHMID, E., WINTER, S., OSBORN, M., and WEBER, K. 1979. Widespread occurrence of intermediate-sized filaments of the vimentin-type in cultured cells from diverse vertebrates. Exp. Cell Res., 123: 25-46.
7. HLAVIN, M.L. and LEMMON, V. 1991. Molecular structure and functional testing of human L1 CAM: An interspecies comparison. Genomics, 11: 416-423.
8. ISHII, K. 1990. Isolation of thymidine-requiring variants from rat nerve-like cells. Cell Struct. Funct., 15: 93-97.
9. ISHII, K., ADACHI, Y., HATANAKA, M., SAKAMOTO, H., and FURUYAMA, J. 1990. Spontaneous and cAMP-dependent induction of a resting phase and neurite formation in cell hybrids between human neuroblastoma cells and thymidine auxotrophs of rat nerve-like cells. J. Cell. Physiol., 143: 569-576.
10. ISHII, K., INOUE, H., HAKURA, A., ARAKI, W., and MASUDA, T. 1992. Immortalization of fetal mouse brain glial cells by human papillomavirus type 16 E7 genes. Cell Struct. Funct., 17: 197-202.
11. ISHII, K., KATAYAMA, M., MASUTANI, H., FURUKE, K., TAKEDA, K., and MASUDA, T. 1993. Monoclonal antibodies reactive with human neuroblastoma cells. Cell Struct. Funct., 18: 629.
12. IWAMATSU, A. 1992. S-carboxymethylation of proteins transferred onto polyvinylidene difuloride membranes followed by in situ protease digestion and amino acid microsequencing. Electrophoresis, 13: 142-147.
13. JENNINGS, M.T., JENNINGS, V.D.L., ASADOURIAN, L.L.H., ROSENBLUM, M., ALBINO, A.P., CAIRNCROSS, J.G., and OLD, L.J. 1989. Five novel cell surface antigens of CNS neoplasms. J. Neurol. Sci., 89: 63-78.
14. KEMSHEAD, J.T., WALSH, F., PRITCHARD, J., and GREAVES, M. 1981. Monoclonal antibody to ganglioside GQ discriminates between haemopoietic cells and infiltrating neuroblastoma tumour cells in bone marrow. Int. J. Cancer, 27: 447-452.
15. KEMSHEAD, J.T., FRITSCHY, J., GARSON, J.A., ALLAN, P., COAKHAM, H., BROWN, S., and ASSER, U. 1983. Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells. Int. J. Cancer, 31: 187-195.
16. KENNETT, R.H. and GILBERT, F. 1979. Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain. Science, 203: 1120-1121.
17. KONDO, S. and ASO, K. 1981. Establishment of a cell line of human skin squamous cell carcinoma in vitro. British J. Dermatol., 105: 125-132.
18. KYRITSIS, A.P., TSOKOS, M., TRICHE, T.J., and CHADER, G.J. 1984. Retinoblastoma - origin from a primitive neuroectodermal cell? Nature, 307: 471-473.
19. LAEMMLI, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680-685.
20. MAEDA, K., FEYLES, V., MCGARRY, R.C., and JERRY, L.M. 1990. Melanocytic differentiation of human neuroblastoma: Expression of a human melanosome-associated antigen. J. Invest. Dermatol., 95: 665-670.
21. MATSUMOTO, M., AKIYAMA, T., MIYATAKE, S., ODA, Y., KIKUCI, H., HANAOKA, M., and NAMBA, Y. 1989. Expression of proto-oncogene products during drug-induced differentiation of a neuroblastoma cell line SK-N-DZ. Acta Neuropathol., 79: 217-221.
22. MATTES, M.J., CORDON-CARDO, C., LEWIS, J.L., Jr., OLD, L.J., and LLOYD, K.O. 1984. Cell surface antigens of human ovarian and endometrial carcinoma denned by mouse monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 81: 568-572.
23. MOOS, M., TACKE, R., SCHERER, H., TEPLOW, D., FRUEH, K., and SCHACHNER, M. 1988. Neural adhesion molecule L1 as a member of immunoglobulin superfamily with binding domains similar to fibronectin. Nature, 334: 701-703.
24. PARYSEK, L.M., CHISHOLM, R.L., LEY, C.A., and GOLDMAN, R.D. 1988. A type III intermediate filament gene is expressed in mature neurons. Neuron, 1: 395-401.
25. RATHJEN, F.G. and SCHACHNER, M. 1984. Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. EMBO J., 3: 1-10.
26. RETTIG, W.J., SPENGLER, B.A., CHESA, P.G., OLD, L.J., and BIEDLER, J.L. 1987. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants. Cancer Res., 47: 1383-1389.
27. SCHOENMANN, S.M., IYER, J., LAENG, H., GERBER, H.A., KAESER, H., and BLASER, K. 1986. Production and characterization of monoclonal antibodies against human neuroblastoma. Int. J. Cancer, 37: 255-262.
28. SUGIMOTO, T., KATO, T., SAWADA, T., HORII, Y., KEMSHEAD, J.T., HINO, T., MORIOKA, H., and HOSOI, H. 1988. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. Cancer Res., 48: 2531-2537.
29. TAKAHASHI, T., UEDA, R., SONG, X., NISHIDA, K., SHINZATO, M., NAMIKAWA, R., ARIYOSHI, Y., OTA, K., KATO, K., NAGATSU, T., IMAIZUMI, M., ABE, T., and TAKAHASHI, T. 1986. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35. Cancer Res., 46: 4770-4775.
30. THOMAS, J.O., NIJJAR, J., TURLEY, H., MICKLEM, K., and GATTER, K.C. 1991. NB84: a new monoclonal antibody for the recognition of neuroblastoma in routinely processed material. J. Pathol., 163: 69-75.
31. THOR, G., PROBSTMEIER, R., and SCHACHNER, M. 1987. Characterization of the cell adhesion molecules L1, N-CAM and J1 in the mouse intestine. EMBO J., 6: 2581-2586.
32. YAMAUCHI, A., MASUTANI, H., TAGAYA, Y., WAKASUGI, N., MITUI, A., NAKAMURA, H., INAMOTO, T., OZAWA, K., and YODOI, J. 1992. Lymphocyte transformation and thiol compounds; the role of ADF/thioredoxin as an endogenous reducing agent. Mol. Immunol., 29: 263-270.
33. ZAGON, I.S. and SCHENGRUND, C.-L. 1978. Neuronal and non-neuronal properties of neuroblastoma cells. Exp. Cell Res., 114: 159-165.